Government ❯ Policy

Healthcare

Pharmaceutical Industry Medicaid Pharmaceutical Policy Disability Services Reforms Insurance Voting Rights Public Health Medical Education Health Insurance Insurance Regulations Child Gender Services Reproductive Rights Medicare Community Health Pharmaceuticals Drug Approval Transportation MedTech Transgender Healthcare Nursing Homes Vaccine Procurement Affordable Care Act Obamacare Access to Healthcare Terminal Illness Pharmaceutical Regulations

AstraZeneca Invests $2 Billion to Expand Maryland Biologics and Build New Clinical Site

The commitment marks the fourth leg of its $50 billion U.S. expansion targeting operational readiness in 2029.

Blog Terms of Service Privacy Policy Help Partners About Us

Copyright © 2025 Mina Labs Inc.